266 related articles for article (PubMed ID: 12423681)
21. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
22. The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors.
Costello R; Mallet F; Chambost H; Sainty D; Arnoulet C; Gastaut JA; Olive D
Leukemia; 1999 Oct; 13(10):1513-8. PubMed ID: 10516751
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor alpha modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia.
Bergamaschi G; Cazzola M; Rosti V; Carlo-Stella C; Santini V; Ponchio L; Peverali FA; Della Valle G; Rossi Ferrini P; Ascari E
Leukemia; 1991 Oct; 5(10):886-91. PubMed ID: 1961022
[TBL] [Abstract][Full Text] [Related]
24. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor-alpha-induced proliferation requires synthesis of granulocyte-macrophage colony-stimulating factor.
Quentmeier H; Dirks WG; Fleckenstein D; Zaborski M; Drexler HG
Exp Hematol; 2000 Sep; 28(9):1008-15. PubMed ID: 11008013
[TBL] [Abstract][Full Text] [Related]
26. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
27. TNF alpha acts in synergy with GM-CSF to induce proliferation of acute myeloid leukemia cells by up-regulating the GM-CSF receptor and GM-CSF gene expression.
Brailly H; Pebusque MJ; Tabilio A; Mannoni P
Leukemia; 1993 Oct; 7(10):1557-63. PubMed ID: 8412318
[TBL] [Abstract][Full Text] [Related]
28. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
29. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
[TBL] [Abstract][Full Text] [Related]
30. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
31. Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells.
Boyer MW; Waller EK; Bray RA; Unangst T; Johnson TS; Phillips C; Jurickova I; Winton EF; Yeager AM
Leukemia; 2000 Mar; 14(3):412-8. PubMed ID: 10720135
[TBL] [Abstract][Full Text] [Related]
32. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
[TBL] [Abstract][Full Text] [Related]
33. Differential binding activity of the transcription factor LIL-STAT in immature and differentiated normal and leukemic myeloid cells.
Tuyt LM; Bregman K; Lummen C; Dokter WH; Vellenga E
Blood; 1998 Aug; 92(4):1364-73. PubMed ID: 9694725
[TBL] [Abstract][Full Text] [Related]
34. The generation of leukemic dendritic cells from acute myeloid leukemia cells is potentiated by the addition of CD40L at the terminal maturation stage.
Lee JJ; Choi BH; Nam JH; Park MS; Song WH; Yang DH; Kim YK; Cho SH; Chung IJ; Park KS; Lee IK; Kim HJ
J Clin Apher; 2004; 19(3):130-6. PubMed ID: 15493054
[TBL] [Abstract][Full Text] [Related]
35. Effect of interleukin-1, tumor necrosis factor-alpha, and interferon-alpha on the blast cells of acute myeloblastic leukemia.
Carter A; Silvian-Draxler I; Tatarsky I
Am J Hematol; 1992 Aug; 40(4):245-51. PubMed ID: 1503080
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-1 and interleukin-2 control granulocyte- and granulocyte-macrophage colony-stimulating factor gene expression and cell proliferation in cultured acute myeloblastic leukemia.
Cozzolino F; Torcia M; Bettoni S; Aldinucci D; Burgio VL; Petti MC; Rubartelli A; Barbui T; Rambaldi A
Int J Cancer; 1990 Nov; 46(5):902-7. PubMed ID: 1699903
[TBL] [Abstract][Full Text] [Related]
37. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
[TBL] [Abstract][Full Text] [Related]
38. Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo.
Paquette RL; Hsu N; Said J; Mohammed M; Rao NP; Shih G; Schiller G; Sawyers C; Glaspy JA
Leukemia; 2002 Aug; 16(8):1484-9. PubMed ID: 12145689
[TBL] [Abstract][Full Text] [Related]
39. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination.
Stucki A; Rivier AS; Gikic M; Monai N; Schapira M; Spertini O
Blood; 2001 Apr; 97(7):2121-9. PubMed ID: 11264180
[TBL] [Abstract][Full Text] [Related]
40. In vitro effects of insulin-like growth factor-1 (IGF-1) on proliferation and constitutive cytokine secretion by acute myelogenous leukemia blasts.
Frostad S; Bruserud O
Eur J Haematol; 1999 Mar; 62(3):191-8. PubMed ID: 10089897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
